NF-YC Inhibitors

NF-YC inhibitors, as defined here, include a range of chemicals that can indirectly influence the activity of Nuclear transcription factor Y subunit gamma (NF-YC). These inhibitors primarily target transcriptional regulation processes and chromatin remodeling pathways, which are integral to NF-YC's role in gene expression. NF-YC, in conjunction with other NF-Y subunits, binds to CCAAT motifs in promoters, regulating gene transcription. Thus, compounds that modulate the chromatin environment or transcriptional machinery can indirectly impact NF-YC activity. Histone deacetylase inhibitors such as Trichostatin A, SAHA, and RGFP966, by altering chromatin structure, can potentially influence the transcriptional regulation activities of NF-YC. These compounds increase acetylation of histones, leading to a more open chromatin structure, which can impact the binding and function of transcription factors like NF-YC. Similarly, DNA methyltransferase inhibitors like 5-Azacytidine can affect DNA methylation patterns, thereby potentially influencing NF-YC-mediated transcription. Other compounds like Curcumin, Resveratrol, and Genistein, known for their broad spectrum of biological activities, including the modulation of various transcription factors, can indirectly affect NF-YC's activity. BET bromodomain inhibitors such as JQ1 target proteins that recognize acetylated histones, thus potentially impacting transcriptional processes involving NF-YC. Additionally, compounds like Caffeic Acid Phenethyl Ester (CAPE), Sulforaphane, Disulfiram, and Quercetin modulate different aspects of cell signaling and gene expression, thereby having the potential to indirectly influence NF-YC's function.